Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)

NCT06393504 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

2095

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia Disorder

Interventions

DRUG: Daridorexant
DRUG: Non-orexin receptor antagonist insomnia medication
OTHER: No insomnia medication

Sponsor

Idorsia Pharmaceuticals Ltd.

Collaborators

[object Object]